Conducting an economic analysis to assess the electrocardiogram's value

Journal of Electrocardiology

Volumn 39, Issue 2, 2006, Pages 241-247

  Eisenstein, Eric L ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Cost and cost analysis; Cost effectiveness myocardial infarction; Electrocardiogram

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; ELECTROCARDIOGRAM; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; HUMANS; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); TELEMEDICINE; TIME FACTORS;

EID: 33645400878     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2005.08.012     Document Type: Article

References (22)

1. M.F. Drummond, and T.O. Jefferson Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party BMJ 313 1996 275
2. E.L. Eisenstein, and D.B. Mark Cost effectiveness of new diagnostic tools and therapies for acute coronary syndromes E.J. Topol Acute coronary syndromes 3rd ed. 2004 Marcel Dekker New York 723
3. M.R. Gold, J. Siegel, L. Russell, and M. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York (NY)
4. H. Day An intensive coronary care area Dis Chest 44 1963 423
5. E.B. Koch, and S.J. Reiser Critical care: historical development and ethical considerations I.A. Fein M.A. Strosbers Managing the clinical care unit 1987 Aspen Rockville (MD) 3
6. M. Hilberman The evolution of intensive care units Crit Care Med 3 1975 159
7. S.J. Reiser The intensive care unit. The unfolding ambiguities of survival therapy Int J Technol Assess Health Care 8 1992 382
8. J.F. McNeer, G.S. Wagner, P.B. Ginsburg, A.G. Wallace, C.B. McCants, and M.J. Conley Hospital discharge one week after acute myocardial infarction N Engl J Med 298 1978 229
9. L.K. Newby, E.L. Eisenstein, R.M. Califf, T.D. Thompson, C.L. Nelson, and E.D. Peterson Cost effectiveness of early discharge after uncomplicated acute myocardial infarction N Engl J Med 342 2000 749
10. K.P. Rentrop, H. Blanke, K.R. Karsch, V. Wiegand, H. Kostering, and H. Oster Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase Clin Cardiol 2 1979 354
11. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Lancet 2 1988 349
12. L.K. Newby, W.R. Rutsch, R.M. Califf, M.L. Simoons, P.E. Aylward, and P.W. Armstrong Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators J Am Coll Cardiol 27 1996 1646
13. R.M. Califf, and L.K. Newby How much do we gain by reducing time to reperfusion therapy? Am J Cardiol 78 1996 8
14. T. Nagle, and R. Holden The strategy and tactics of pricing: a guide to profitable decision making 2002 Prentice Hall Upper Saddle River (NJ)
15. P. Doubilet, M.C. Weinstein, and B.J. McNeil Use and misuse of the term "cost effective" in medicine N Engl J Med 314 1986 253
16. L. Goldman, M.C. Weinstein, P.A. Goldman, and L.W. Williams Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease JAMA 265 1991 1145
17. US Renal Data System: USRDS 2004 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2004.
18. Donaldson C, Mugford M, Vale L. Using systematic reviews in economic evaluation. Evidence-based Health Economics. From Effectiveness to Efficiency in Systematic Review. London, 2002.
19. E.L. Eisenstein, K.J. Anstrom, J.A. Arbanas, D.R. Crosslin, F.S. Johnson, and K. Kawamoto Assessing the potential economic value of health information technology interventions in a community-based health network AMIA Symposium 2005 2005 [in press]
20. C. Scales, P. Jones, E. Eisenstein, G. Preminger, and D. Albala Local cost structures and the economics of robot assisted radical prostatectomy J Urol 2005 [in press]
21. E.L. Eisenstein, L.K. Shaw, K.J. Anstrom, C.L. Nelson, Z. Hakim, and V. Hasselblad Assessing the clinical and economic burden of coronary artery disease: 1986-1998 Med Care 39 2001 824
22. P. Kaul, P.W. Armstrong, P.A. Cowper, E.L. Eisenstein, C.B. Granger, and F. Van de Werf Economic analysis of the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction Am Heart J 149 2005 637